Symposia

    Overview of Symposia

    S - Symposia

    S-1  Where do we end? How imbalances in sensory-processing and self disorders may disrupt world-self boundaries in psychosis

    Chair: S. Damiani, University Pavia, Italy
    Co-Chair: A. Estrade, University Pavia, Italy

    Self-disorders: phenomenology and role in the formation of prodromes and 
    psychotic symptoms
    Andres Estrade 
    Istitute of Psychology and Neuroscience, King's College, London
    Self-other discrimination: source monitoring and false perceptions within the framework of self disturbances in psychopathology;Lukasz Gaweda
    Polish Academy of Sciences PAN, Institute of Psychology, Warsaw
    Self-other interactions: the characterization of social cognition deficits during
    the early stages of psychosis;
    Ana Catalan
    LMU Munich
    World-self boundaries: the relationship between self and perception in psychosis. Tools to measure it (eg. peri-personal space, world-self ambivalence) and 
    the impact of perceptual processing
    Stefano Damiani
    University of Pavia, Dept., of Brain & Behavioral Sciences,

     

    S-2  Exploring frontostriatal circuits and potential biomarkers for reward processing in patients with schizophrenia – relevance for negative symptoms

    Chair: Stefan Kaiser, Geneva, Switzerland
    Co-Chair: Florian Schlagenhauf, Charite, Berlin, Germany

      

    Electrophysiological Correlates of Reward Dysfunctions and Negative Symptoms 
    in Schizophrenia
    Giulia Maria Giordano 
    Naples, Italy                                   
    Alterations in reward processing as biomarkers in schizophreniaMariia Kaliuzhna 
    University Geneva, Genf
    Altered belief updating in patients with schizophreniaFlorian Schlagenhauf 
    Charité, Berlin
    Negative symptoms, dopamine, and model-based and model-free decision making      Christian Sorg 
    LMU Munich

     

    S-3  Early detection and early intervention of bipolar disorders: New results

    Chair: Andreas Bechdolf, Vivantes Klinikum am Urban und im Friedrichshain, Charité Universitätsmedizin, Berlin, Germany
    Co-Chair: Sophie Parker, Youth Mental Health Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK 

    Young People At Risk for Developing Bipolar Disorder: First Two-Year Findings from the Multicenter Prospective, Naturalistic Early-BipoLife StudyAndrea Pfennig
    University of Dresden
    Frequency and Predictors of Emerging Bipolar-Spectrum Disorders in Adolescents Hospitalized for Non-psychotic Mental Health Problems: Results from a Prospective StudyChristoph U. Correll
    Charité, Berlin
    The Long-Term Prospective Validity of Bipolar At-Risk Criteria in Clinically Help-Seeking Young PeopleAndreas Bechdolf, 
    Vivantes Klinikum am Urban 
    und im Friedrichshain and Charité, Berlin
    A novel treatment for young people at high-risk of developing bipolar disorder using cognitive therapy: CBTBAR                                                                                                                                                                                                                                                                                                                                                    Sophie Parker
    Youth Mental Health Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester

     

    S-4 Effects of exercise interventions on clinical outcome and brain plasticity in schizophrenia

    Chair: Peter Falkai, LMU, Munich, Germany
    Co-Chair: Wiepke Cahn, University Utrecht, NL 

    Effects of physical exercise on cognition and clinical symptoms of
    schizophrenia: results from the multicentre ESPRIT study
    Isabel Maurus
    Department of Psychiatry 
    and Psychotherapy, LMU Munich
    Implementing exercise as a therapeutic strategy for schizophrenia.Wiepke Cahn
    University Medical Center Utrecht
    Physical exercise and brain plasticity in schizophreniaLukas Röll
    Department of Psychiatry 
    and Psychotherapy, LMU Munich
    Combining aerobic exercise with clemastine to promote myelin plasticity                            Peter Falkai, 
    LMU University Hospital, Munich

     

    S-5  The motor dimension of psychosis

    Chair: Sebastian Walther, Bern, Switzerland, and Würzburg, Germany
    Co-Chair: Peter van Harten, Maastricht, NL

    Neural correlates of psychomotor slowing and treatment options using 
    transcranial magnetic stimulation
    Sebastian Walther
    Bern & Würzburg
    Central role of motor areas for negative symptom factors in schizophrenia                         Katharina Stegmayer
    Bern
    Acute drug-induced movement disordersPeter van Harten
    Maastricht

     

    S-6  Promoting understanding of emerging psychosis: new findings on basic symptoms

    Chair: Frauke Schultze-Lutter, Department of Psychiatry and Psychotherapy Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Germany
    Co-Chair: Joachim Klosterkötter, Germany

    The “substrate-closeness” of basic symptoms: a historical viewJoachim Klosterkötter
    University Hospital Cologne
    The biological correlations of visual basic symptomsRebecca Lencer
    University Hospital Schleswig-Holstein Lübeck
    The association of basic symptoms with personality characteristicsMarius Wrulich
    University Hospital HHU, 
    Düsseldorf
    Basic symptoms in the community: results of the Bern Epidemiological At-Risk (BEAR) studyFrauke Schultze-Lutter
    University Hospital, HHU, Düsseldorf

     

    S-7  Dysfunctional brain connectivity and markers of inflammation in psychoses

    Chair: Paola Bucci, University of Campania “Luigi Vanvitelli”, Naples, Italy
    Co-Chair: Matthias Kirschner, Division of Adult Psychiatry, Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland

    Cytokine levels as a predictor of social functioning in subjects with ultra-high risk for psychosis: A multicenter cohort studyTomiki Sumiyhoshi/ Yuji Yamada
    Department of Preventive 
    Intervention for Psychiatric Disorders, 
    National Institute of Mental Health, 
    National Center of Neurology 
    and Psychiatry, Kodaira, Tokyo
    Neuroimaging correlates of inflammation in subjects with first-episode schizophreniaGiulia Cattarinussi
    Department of Psychological Medicine, 
    Institute of Psychiatry, Psychology and Neuroscience, King’s College London, 
    London
    Illness-related variables and abnormalities of resting-state brain functional connectivity in schizophreniaGiulia Maria Giordano
    University of Campania 
    “Luigi Vanvitelli”, Naples
    Connectome architecture shapes large-scale cortical alterations in schizophrenia: a worldwide ENIGMA studyMatthias Kirschner
    Division of Adult Psychiatry, 
    Department of Psychiatry, 
    Geneva University Hospitals, Geneva

     

    S-8  The Synaptic Hypothesis of Schizophrenia: A 21st Century Update

    Chair: Ellis Chika Onwordi, Wolfson Institute of Population Health, Queen Mary University of London, UK
    Co-Chair: Peter Falkai, LMU, Munich, Germany

    Identifying candidate schizophrenia treatment targets from brain-enriched isoforms
    of CACNA1C
    Nicola Hall 
    Department of Psychiatry, 
    University of Oxford, UK
    Modelling brain maturation to unveil the basis of synapse loss in schizophreniaCarl Sellgren 
    Department of Physiology and 
    Pharmacology, Karolinska Institute
    Reduced synaptic density in schizophrenia: evidence from in vivo PET studiesEllis Chika Onwordi
    Wolfson Institute of Population Health, 
    Queen Mary University of London
    Aerobic exercise enhances synaptic plasticity in schizophreniaPeter Falkai
    LMU University Hospital, Munich

     

    S-9  The art of prescribing clozapine: novel developments in the treatment with clozapine

    Chair: Dan Cohen, MHO North-Holland North, NL
    Co-Chair: Hein de Haas, Amsterdam, The Netherlands 

    Treatment outcome in long-term clozapine treatmentDan Cohen
    MHO North-Holland North
    Substance use disorder in schizophrenia: a neglected therapeutic
    effect of  clozapine
    Hein de Haas
    Arkin, Amsteram
    An evidence-based proposal for the relaxation of the regulations 
    for mandatory   leukocyte monitoring.  
    P.F. J. Schulte
    MHO North-Holland North
    Does neutrophil fluorescence mark treatment adherence to clozapine?                        W.H. Man
    Meander Medical Center, Amersfoort

     

    S-11 CBT interventions for patients at-clinical high risk of psychosis, patients with early psychosis, and patients with acute delusions: results of pilot trials and randomized-controlled trials

    Chair: Stephanie Mehl, Department of Psychiatry and Psychotherapy, Philipps-University of Marburg, Germany
    Co-Chair: Andreas Bechdolf, Vivantes Klinikum am Urban und im Friedrichshain, Charité Universitätsmedizin, Berlin, Germany

    Results of the Prevent-Study and prediction of transition to psychosis, 
    psychopathology and social functioning
    Henrik Müller
    Department of Psychiatry and 
    Psychotherapy, University of Cologne
    Feasibility and Efficacy of an Acceptance and Mindfulness-Based Group
    Intervention for Young People with Early Psychosis (Feel-Good-Group)                         
    Andreas Bechdolf
    Department of Psychiatry and 
    Psychotherapy, Charité, Berlin
    Efficacy of an emotion-oriented version of Cognitive Behavior Therapy
    for patients with delusions (CBTd-E) in comparison to wait list 
    in a single-blinded randomized-controlled trial
    Stephanie Mehl
    Department of Psychiatry and 
    Psychotherapy, 
    Philipps-University of Marburg

     

    S-12  Unraveling Cerebellar Contributions to Symptoms in Schizophrenia: Insights into Pathophysiology and Therapeutic Circuit-Guided Targets

    Chair: Indrit Bègue, Laboratory for Neuroimaging and Translational Psychiatry, Department of psychiatry, University of Geneva & University Hospitals of Geneva, Geneva, Switzerland
    Co-Chair: Catherine Stoodley, Developing Brain Institute, Children’s National Hospital, Departments of Neurology and Pediatrics, George Washington School of Medicine and Health Sciences, Washington DC, USA

    Cerebellar modulation of behavior, brain activation, and neural networks relevant to psychosis  Chatherine Stoodley
    Developing Brain Institute Children’s 
    National Hospital Departments of Neurology 
    and Pediatrics 
    George Washington School of Medicine and Health Sciences, Washington DC
    Down to the nitty-gritty of ‘cognitive dysmetria: Precision mapping of cerebellar connectivity to cognition and psychopathology in psychosisHengyi Cao
    Institute of Behavioral Science, 
    Feinstein Institutes for Medical Research
    Division of Psychiatry Research, 
    Zucker Hillside Hospital New York
    Dynamic connectivity patterns of the cerebellum and ventral tegmental area relate to negative symptoms of schizophrenia and are stable over timeIndrid Bègue
    Laboratory for Neuroimaging and 
    Translational Psychiatry 
    Department of Psychiatry
    University of Geneva 
    & University Hospitals of Geneva
    Therapeutic noninvasive neuromodulation of cerebellumMark A. Halko
    Schizophrenia and Bipolar Disorder Research Program McLean Hospital, Belmont
    Harvard Medical School, Boston

     

    S-13  Early detection of depression: a life-course perspective

    Chair: N. Wege, HHU Düsseldorf, Germany
    Co-Chair: E. Greimel, KJPP LMU, Germany

    „ich bin alles“: Information portal on depression and mental health 
    in children and adolescents - a project aiming at improving depression
    literacy, prevention and early intervention
    Sara Kaubisch
    LMU Hospital Munich
    Prediction of deterioration of depressive symptom severity among 
    older adults – results from the 1000BRAINS population-based studies
    Julia Christl
    University Hospital, HHU, Düsseldorf
    Stressors that trigger the depressive episode from patients‘ perspectiveNatalia Wege
    University Hospital, HHU, Düsseldorf
     
    The influence of subclinical depressive symptoms on cognition 
    and functional connectivity in old age
    Pascal Grumbach
    Research/Science Center Jülich  

     

    S-14  Perceived Threat: Advances in Understanding Psychological, Physiological, Neurobiological and Molecular Factors of Paranoia

    Chair: Katharina Stegmayer, University Hospital of Psychiatry and Psychotherapy, University of Bern, Switzerland
    Co-Chair: Michal Hajdúk, Comenius University, Bratislava, Slovakia

    The Role of Paranoia in the Perception of Social Interaction in 
    Schizophrenia Spectrum Disorders – Behavioral and Psychophysiological Correlates
    Michal Hajdúk
    Comenius University in Bratislava
    Safety Behaviours Maintain Paranoid Delusions in the Daily Life of Individuals with Psychotic Disorders: Evidence from an Ecological Momentary Assessment StudySven Schönig
    Department of Clinical Psychology & Psychotherapy, University Hamburg
    Altered interpersonal space in schizophrenia is associated with paranoia, altered stress regulation, and unfavourable outcomes in 6 months’ follow-upAdamantini Chatzipanagioti
    University Hospital of Psychiatry and Psychotherapy, University of Bern
    Paranoia is associated with markers of parvalbumin interneuron pathology and structural and functional alterations in the amygdala and ventral hippocampus in schizophreniaKatharina Stegmayer
    University Hospital of Psychiatry and Psychotherapy, University of Bern 
     

     

    S-16  Translation in Psychiatry: Early detection of psychosis, computer-assisted diagnostics and risk-adapted therapy: The CARE Project 

    Chair: Eva Meisenzahl, Heinrich-Heine-University Düsseldorf, Germany
    Co-Chair: Nikolaos Koutsouleris, Clinic of Psychiatry, University LMU, Munich, Germany

    The challenge of translationEva Meisenzahl
    University Hospital, HHU, Düsseldorf
    Clinic of early detection in psychosisFrauke Schultze-Lutter 
    University Hospital, HHU, Düsseldorf
    Computer-based systems in CARENikolaos Koutsouleris
    LMU University Hospital, Munich
     
    Risk adapted therapy in HR psychosis                                                                                  Ursula Leyens
    University Hospital, HHU, Düsseldorf

     

    S-17 Gene-environment interactions in affective disorders and psychosis: results from imaging genetics, epigenetics and psychophysiology

    Chair: Philipp Sämann, Neuroimaging Core Unit, Max Planck Institute of Psychiatry, Munich, Germany
    Co-Chair: Sergi Papiol, Max Planck Institute of Psychiatry, Munich, Germany

    Modulatory role of polygenic load on the beneficial effects of physical activity on hippocampus volumes in chronic schizophrenia patientsSergi Papiol
    Max-Planck Institute of Psychiatry, Munich
    Endophenotype potential of nucleus accumbens functional connectivity: 
    effects of polygenic risk for schizophrenia interacting with childhood adversity
    Philipp Sämann
    Max-Planck Institute of Psychiatry, Munich
    Epigenetic age acceleration: principle and correlations with psychiatric 
    disease load and neurocognition
    N. Yusupov
    Max-Planck Institute of Psychiatry, Munich
    Data-driven cognitive pupillometric response profiles and their polygenic
    relationship to educational attainment
     J. Fietz
    Max Planck Institute of Psychiatry

    SO - Symposia (Oral Presentations)

    SO-10

    SO-10-O1:
    Cornelius Ehlers, Alberta Health Services, Addiction and Mental Health, Red Deer, Alberta, Canada
    Perceived Client Experiences of Participants supported by the Children and Adolescent Stabilization Team in Red Deer, Alberta

    SO-10-O2: 
    Marco Zierhut, Charité – Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Berlin, Germany
    The effect of mindfulness-based group psychotherapy on biological and psychological stress parameters in schizophrenia spectrum disorders

    SO-10-O3: 
    Seval Bekiroğlu, Başkent University, Faculty of Health Sciences, Social Work Department, Ankara, Turkey
    The Family Experiences of Individuals Diagnosed with Schizophrenia in Turkey: A Qualitative Study

    SO-10-O4: 
    Vladislav Yakimov, Department of Psychiatry and Psychotherapy, University Hospital LMU, Munich, Germany
    Blood-cerebrospinal fluid barrier integrity is associated with dyslipidemia in schizophrenia-spectrum disorders

     

     

    SO-15

    SO-15-O1: 
    Alp Üçok, Istanbul Faculty of Medicine, Department of Psychiatry, Istanbul, Turkey
    Help-seeking from traditional healers in patients with severe mental illness

    SO-15-O2: 
    Daniela Mier, Department of Psychology, University of Konstanz, Germany
    Perception of trust and sexually transmitted infections in schizophrenia patients 

    SO-15-O3:
    Jana von Trott, LMU Munich, Germany
    Early Recognition and Prediction of Psychosis and other Mental Health Diseases 

    SO-15-O4:
    A. Khuntia, LMU Munich, Germany
    BMI gap: a new tool to quantify obesity-related brain variation